Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2019 Nov 8;18(10):2279–2286.e3. doi: 10.1016/j.cgh.2019.11.011

Table 3.

Inflammatory potential of diet and risk of diverticulitis in HPFS according to lifestyle characteristics*

Quintiles of inflammatory potential of diet score P for interaction

1 2 3 4 5 P for trend
Body mass index 0.68
 < 25 kg/m2 (n=400), HR (95% CI) 1.0 (ref) 1.00 (0.73, 1.36) 1.16 (0.84, 1.60) 1.01 (0.73, 1.41) 1.32 (0.96, 1.84) 0.12
 ≥ 25 kg/m2 (n=708), HR (95% CI) 1.0 (ref) 1.21 (0.94, 1.56) 1.20 (0.93, 1.56) 1.27 (0.99, 1.64) 1.34 (1.04, 1.72) 0.03
Vigorous activity 0.25
 No (n=523), HR (95% CI) 1.0 (ref) 1.22 (0.91, 1.64) 1.23 (0.91, 1.65) 1.27 (0.95, 1.70) 1.26 (0.94, 1.69) 0.13
 Yes (n=587), HR (95% CI) 1.0 (ref) 1.06 (0.81, 1.38) 1.14 (0.87, 1.50) 1.07 (0.81, 1.41) 1.39 (1.06, 1.82) 0.03
*

Inflammatory potential of diet score was adjusted for total energy using the residual method. Higher EDIP scores indicating pro-inflammatory dietary patterns whereas lower scores indicate anti-inflammatory dietary patterns.

Models were adjusted for age (continuous, years), body mass index (<22.5, 22.5–24.9, 25.0–27.4, 27.5–29.9, 30.0–34.9, ≥35.0 kg/m2), vigorous activity (0, 0.1–3.4, 3.5–10.4, 10.5–28.4, ≥28.5 MET-h/week), smoking status (never smoker, past smoker, current smoker (1–14, 15–24, ≥25 cigarettes/d)), alcohol consumption (0, 0–4.9, 5.0–9.9, 10.0–14.9, 15.0–29.9, ≥30 g/d), aspirin use (yes/no), acetaminophen use (yes/no), use of other NSAIDs (yes/no), multivitamin use (yes/no), and physical examination for symptoms or routine screening (yes/no), with omission of the effect modifier of interest in the corresponding model.

n indicates number of cases.